RemeGen Co (SHSE:688331) 3-Year Book Growth Rate : -7.40% (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is RemeGen Co 3-Year Book Growth Rate?

RemeGen Co's Book Value per Share for the quarter that ended in Dec. 2023 was ¥6.32.

During the past 12 months, RemeGen Co's average Book Value per Share Growth Rate was -32.40% per year. During the past 3 years, the average Book Value per Share Growth Rate was -7.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 6 years, the highest 3-Year average Book Value per Share Growth Rate of RemeGen Co was -7.40% per year. The lowest was -7.40% per year. And the median was -7.40% per year.

Competitive Comparison of RemeGen Co's 3-Year Book Growth Rate

For the Biotechnology subindustry, RemeGen Co's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

RemeGen Co's 3-Year Book Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, RemeGen Co's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where RemeGen Co's 3-Year Book Growth Rate falls into.

RemeGen Co 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

RemeGen Co (SHSE:688331) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.

RemeGen Co 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of RemeGen Co's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

RemeGen Co (SHSE:688331) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » RemeGen Co Ltd (SHSE:688331) » Definitions » 3-Year Book Growth Rate

Comparable Companies

Traded in Other Exchanges

REGMF:USA 09995:Hong Kong REG:Germany

Address

58 Middle Beijing Road, Yantai Area of Shandong Pilot Free Trade Zone, Yantai Development Zone, Yantai, CHN

Website

http://www.remegen.com

RemeGen was established in 2008 and listed on the Hong Kong Stock Exchange in 2020. It is a commercial stage biotech company focused on developing drugs to treat autoimmune disease, cancer, and ophthalmic disease for the China market and potentially the global market, as well. Its core assets are disitamab vedotin (RC48), a HER2-targeting antibody-drug conjugate (ADC) for treating HER2-expressing cancers, and telitacicept (RC18), a BLyS and APRIL targeting bispecific fusion protein for treating various B-cell mediated autoimmune diseases. These drugs received their first approvals in China in 2021 and are both covered on the National Reimbursement Drug List (NRDL).

RemeGen Co (SHSE:688331) Headlines

No Headlines